List of Tables
    Table 1. Antipsychotic Medications CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Antipsychotic Medications Market Trends
    Table 3. Antipsychotic Medications Market Drivers
    Table 4. Antipsychotic Medications Market Challenges
    Table 5. Antipsychotic Medications Market Restraints
    Table 6. Global Antipsychotic Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Antipsychotic Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Antipsychotic Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Antipsychotic Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Antipsychotic Medications Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Antipsychotic Medications Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Antipsychotic Medications Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Antipsychotic Medications Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Antipsychotic Medications Sales Share by Manufacturer, 2017-2022
    Table 15. Global Antipsychotic Medications Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Antipsychotic Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Antipsychotic Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medications as of 2021)
    Table 18. Top Players of Antipsychotic Medications in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Antipsychotic Medications Product Type
    Table 20. Date of International Manufacturers Enter into Antipsychotic Medications Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Antipsychotic Medications Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Antipsychotic Medications Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Antipsychotic Medications Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Antipsychotic Medications Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Antipsychotic Medications Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Antipsychotic Medications Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Antipsychotic Medications Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Antipsychotic Medications Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Antipsychotic Medications Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Antipsychotic Medications Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Antipsychotic Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Antipsychotic Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Antipsychotic Medications Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Antipsychotic Medications Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Antipsychotic Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Antipsychotic Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Antipsychotic Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Antipsychotic Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Antipsychotic Medications Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Antipsychotic Medications Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Johnson and Johnson Corporation Information
    Table 43. Johnson and Johnson Description and Business Overview
    Table 44. Johnson and Johnson Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Johnson and Johnson Antipsychotic Medications Product
    Table 46. Johnson and Johnson Recent Development
    Table 47. Eli Lilly Corporation Information
    Table 48. Eli Lilly Description and Business Overview
    Table 49. Eli Lilly Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Eli Lilly Product
    Table 51. Eli Lilly Recent Development
    Table 52. Bristol-Myers Squibb Corporation Information
    Table 53. Bristol-Myers Squibb Description and Business Overview
    Table 54. Bristol-Myers Squibb Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Bristol-Myers Squibb Product
    Table 56. Bristol-Myers Squibb Recent Development
    Table 57. AstraZeneca Corporation Information
    Table 58. AstraZeneca Description and Business Overview
    Table 59. AstraZeneca Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. AstraZeneca Product
    Table 61. AstraZeneca Recent Development
    Table 62. Novartis Corporation Information
    Table 63. Novartis Description and Business Overview
    Table 64. Novartis Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Novartis Product
    Table 66. Novartis Recent Development
    Table 67. Allergan Corporation Information
    Table 68. Allergan Description and Business Overview
    Table 69. Allergan Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Allergan Product
    Table 71. Allergan Recent Development
    Table 72. Pfizer Corporation Information
    Table 73. Pfizer Description and Business Overview
    Table 74. Pfizer Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Pfizer Product
    Table 76. Pfizer Recent Development
    Table 77. GlaxoSmithKline Corporation Information
    Table 78. GlaxoSmithKline Description and Business Overview
    Table 79. GlaxoSmithKline Antipsychotic Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. GlaxoSmithKline Product
    Table 81. GlaxoSmithKline Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Antipsychotic Medications Customers List
    Table 85. Antipsychotic Medications Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antipsychotic Medications Product Picture
    Figure 2. Global Antipsychotic Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Antipsychotic Medications Market Size 2017-2028 (US$ Million)
    Figure 4. Global Antipsychotic Medications Sales 2017-2028 (K Units)
    Figure 5. United States Antipsychotic Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Antipsychotic Medications Market Size 2017-2028 (US$ Million)
    Figure 7. United States Antipsychotic Medications Sales 2017-2028 (K Units)
    Figure 8. United States Antipsychotic Medications Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Antipsychotic Medications Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Antipsychotic Medications Report Years Considered
    Figure 11. Product Picture of Selective Serotonin Reuptake Inhibitors (SSRIs)
    Figure 12. Product Picture of Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
    Figure 13. Product Picture of Tricyclic Antidepressants (TCAs)
    Figure 14. Product Picture of Monoamine Oxidase Inhibitors (MAOIs)
    Figure 15. Product Picture of Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
    Figure 16. Product Picture of Tetracyclic Antidepressants (TeCAs)
    Figure 17. Product Picture of Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
    Figure 18. Global Antipsychotic Medications Market Share by Type in 2022 & 2028
    Figure 19. Global Antipsychotic Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 20. Global Antipsychotic Medications Sales Market Share in Value by Type (2017-2028)
    Figure 21. Global Antipsychotic Medications Sales by Type (2017-2028) & (K Units)
    Figure 22. Global Antipsychotic Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 23. Global Antipsychotic Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 24. United States Antipsychotic Medications Market Share by Type in 2022 & 2028
    Figure 25. United States Antipsychotic Medications Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 26. United States Antipsychotic Medications Sales Market Share in Value by Type (2017-2028)
    Figure 27. United States Antipsychotic Medications Sales by Type (2017-2028) & (K Units)
    Figure 28. United States Antipsychotic Medications Sales Market Share in Volume by Type (2017-2028)
    Figure 29. United States Antipsychotic Medications Price by Type (2017-2028) & (USD/Unit)
    Figure 30. Product Picture of Hospital Pharmacies
    Figure 31. Product Picture of Drug Stores
    Figure 32. Product Picture of Others
    Figure 33. Global Antipsychotic Medications Market Share by Application in 2022 & 2028
    Figure 34. Global Antipsychotic Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Antipsychotic Medications Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Antipsychotic Medications Sales by Application (2017-2028) & (K Units)
    Figure 37. Global Antipsychotic Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Antipsychotic Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 39. United States Antipsychotic Medications Market Share by Application in 2022 & 2028
    Figure 40. United States Antipsychotic Medications Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Antipsychotic Medications Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Antipsychotic Medications Sales by Application (2017-2028) & (K Units)
    Figure 43. United States Antipsychotic Medications Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Antipsychotic Medications Price by Application (2017-2028) & (USD/Unit)
    Figure 45. North America Antipsychotic Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. North America Antipsychotic Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Antipsychotic Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 50. Europe Antipsychotic Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Antipsychotic Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 57. Asia-Pacific Antipsychotic Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Antipsychotic Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Latin America Antipsychotic Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Antipsychotic Medications Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 74. Middle East & Africa Antipsychotic Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Antipsychotic Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Antipsychotic Medications Value Chain
    Figure 79. Antipsychotic Medications Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed